片段(逻辑)
结核分枝杆菌
药物发现
计算生物学
细胞色素P450
肺结核
酶
情报检索
计算机科学
生物
生物化学
医学
算法
病理
作者
Sean Andrew Hudson,Kirsty J. McLean,Sachin B. Surade,Yongqing Yang,David Leys,Alessio Ciulli,Andrew W. Munro,Chris Abell
标识
DOI:10.1002/anie.201202544
摘要
Pieces of the puzzle: The first fragment-based approach was used to target cytochrome P450 enzymes (CYPs) for drug development (see scheme). The experiments provide new insights into the binding site of the essential Mycobacterium tuberculosis CYP121 enzyme, and resulted in a promising novel lead compound based on fragment merging.
科研通智能强力驱动
Strongly Powered by AbleSci AI